Answers are grounded in this paper and cite their sources.
Obesity has dramatically increased over the last 30 years and reaches according to WHO dimensions of a global epidemic. The obesity-associated chronic low-level inflammation contributes to severe co-morbidities and directly affects many immune cells leading to immune dysfunction and increased susceptibility to infections. Thus prophylaxis against vaccine-preventable diseases is crucial, yet the responsiveness to several vaccines is unclear under obesity. In order to assess the responsiveness to tick-borne encephalitis (TBE) vaccine, we re-vaccinated 37 obese individuals and 36 normal-weight controls with a licensed TBE vaccine. Metabolic, hormonal and immunologic profiles along with vaccine-specific humoral and cellular immune responses were evaluated in sera and PBMC before, 1 week, 4 weeks and 6 months after TBE-booster. Obese adults had significantly increased metabolic (triglycerides, cholesterol ratios, leptin, insulin) and pro-inflammatory (CRP) parameters. They showed stronger initial increase of TBE-specific Ab-titers (d7_d28) followed by a significantly faster decline after 6 months, which correlated with high BMI, leptin and insulin levels. The fold-increase of Ab-titer levels was significantly higher in obese compared to control males and linked to reduced testosterone levels. Obesity also affected cellular responses: PBMC of the obese vaccinees had elevated IL-2 and IFNγ levels upon antigen stimulation, indicating a leptin-dependent pro-inflammatory Th1 polarization. The expansion of total and naïve B-cells in obese might explain the initial increase of Ab-titers, while the reduced B-memory cell and plasma blast generation could be related to fast Ab decline with a limited maintenance of titers. Among Tfh cells, the Tfh17 subset was significantly expanded particularly in obese males, where we observed a strong initial Ab increase. Systemic but not local vaccine side effects were more frequent in obese subjects as a possible consequence of their low-grade pro-inflammatory state. In summary, TBE booster vaccination was effective in obese individuals, yet the faster Ab decline could result in a reduced long-term protection. The sex-based differences in vaccine responses indicate a complex interplay of the endocrine, metabolic and immune system during obesity. Further studies on the long-term protection after vaccination are ongoing, and also evaluation of primary vaccination against TBE in obese individuals is planned.
No takes yet. Share an insight, caveat, or question.
Garner‐Spitzer et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: